Skip to main content
Premium Trial:

Request an Annual Quote

Metabolon, InnVentis Partner to Study Metabolomics in Inflammatory Disease

NEW YORK (GenomeWeb) – Metabolon announced today that it has partnered with Israeli precision medicine firm InnVentis to study metabolomics in individuals with chronic inflammatory diseases such as rheumatoid arthritis.

The deal joins Metabolon's metabolomics expertise with InnVentis' big data and machine learning platform, the company said. Specific terms of the partnership were not disclosed.

"Our goal is to use our proprietary technology in conjunction with InnVentis' platform to provide a more accurate health assessment of patients, as well as clinically useful information," Metabolon CEO John Ryals said in a statement. "Metabolomics may help answer key biological questions about these complex disorders and improve personalized treatment."

InnVentis CEO Thomas Wilckens added that his company is aiming to use metabolomics and other omics technologies "to enable novel, real-time disease management for clinicians and patients.. This will include drug responder identification upon first diagnosis, as well as drug dosing management."

The Scan

Taking Stock of the Stockpile

The US and European countries are evaluating their smallpox vaccine stockpiles as the number of monkeypox cases increases, the Washington Post reports.

Vitamin D From Tomatoes

According to Reuters, researchers in the UK have gene-edited tomatoes so their fruit contains vitamin D.

Cause Not Yet Spotted

NPR reports that a new study was unable to find a cause for persistent long COVID symptoms.

PNAS Papers on Central African Hunter-Gatherers, Myopia Development, Ancient Microtia Allele

In PNAS this week: population patterns among Central African hunter gatherers, effect of myopia-linked gene variant, and more.